Erika Carmel-Tech Ltd (ERKA.TA)
Tel Aviv · ILA · Healthcare · Medical Devices
ILA 43.10 (-6.10%) as of
Key statistics
- Market cap
- 17.96M
- EPS (TTM)
- -0.26
- Dividend yield
- 0.00%
- 52-week range
- 39.30 – 77.50
- Beta
- 1.12
- Revenue (TTM)
- 33.43M
- Profit margin
- -35.57%
- Volume
- 8.68k
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower back pain, neck pain, shoulder pain, knee pain, tennis elbow, toe joint pain, temporomandibular joint disorders, upper back pain, and wounds. The company was formerly known as Erika B-Cure Laser Ltd and changed its name to Erika Carmel-Tech Ltd in October 2025. Erika Carmel-Tech Ltd was incorporated in 2007 and is headquartered in Haifa, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Haifa, Israel
- Employees
- 45
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.